Your session is about to expire
← Back to Search
Non-invasive Brain Stimulation
Brain Stimulation for Schizophrenia
N/A
Waitlist Available
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
All subjects must have the ability to give valid informed consent
No children under the age of 18 will be recruited
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessment begins with the initial baseline interview and concludes after a 2-week follow-up assessment using the same clinical measures.
Awards & highlights
Study Summary
This trial will test if a non-invasive brain stimulation can help reduce symptoms in people with schizophrenia.
Who is the study for?
This trial is for English-speaking adults with a stable mental health status and normal IQ, diagnosed with schizophrenia or related disorders. It's not for those under 18, with recent substance abuse, metal implants, skin conditions at electrode sites, head trauma, epilepsy, severe psychiatric disorders other than schizophrenia spectrum disorders, heart devices like pacemakers or defibrillators, certain hairstyles that interfere with equipment placement on the head.Check my eligibility
What is being tested?
The study tests if transcranial direct current stimulation (tDCS), a non-invasive brain stimulation technique can reduce auditory hallucinations and negative symptoms in people with schizophrenia. Participants' clinical symptoms and cognitive abilities will be measured to see if tDCS has beneficial effects.See study design
What are the potential side effects?
Potential side effects of tDCS may include discomfort at the electrode site on the scalp such as itching or tingling during application; headache; fatigue; nausea; and insomnia. These are generally mild and temporary.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can understand and agree to the study's details on my own.
Select...
I am 18 years old or older.
Select...
I have been diagnosed with schizophrenia or a related disorder.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ assessment begins with the initial baseline interview and concludes after a 2-week follow-up assessment using the same clinical measures.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessment begins with the initial baseline interview and concludes after a 2-week follow-up assessment using the same clinical measures.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Symptom Severity of Auditory Hallucinations
Change in Symptom Severity of Negative Symptoms
Side effects data
From 2021 Phase 2 & 3 trial • 160 Patients • NCT024834682%
Car accident
2%
skin irritation
100%
80%
60%
40%
20%
0%
Study treatment Arm
tDCS (Active)
tDCS (Sham)
Trial Design
1Treatment groups
Experimental Treatment
Group I: dlPFC/TPJ Stimulation + RestExperimental Treatment1 Intervention
20 minutes of 2 mA direct current stimulation during rest.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Direct Current Stimulation
2014
Completed Phase 3
~1100
Find a Location
Who is running the clinical trial?
University of California, DavisLead Sponsor
914 Previous Clinical Trials
4,720,710 Total Patients Enrolled
3 Trials studying Schizophrenia
286 Patients Enrolled for Schizophrenia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have struggled with drug or alcohol addiction in the past six months.I have epilepsy.You have metal implants in your body.I have skin conditions like eczema where electrodes would be placed.I can understand and agree to the study's details on my own.You have a condition called mental retardation.You have a device called a defibrillator implanted in your body.I have a brain condition.I have experienced a head injury.I have a history of neurological or severe psychiatric disorders.You have vision problems that make it difficult for you to complete cognitive tests, especially if you have trouble seeing colors accurately.I am not fully hospitalized and can manage some daily activities.I am 18 years old or older.I have been diagnosed with schizophrenia or a related disorder.You have a pacemaker.You have used drugs or alcohol excessively in the past month.You have implanted devices in your brain or spine that send electrical signals.
Research Study Groups:
This trial has the following groups:- Group 1: dlPFC/TPJ Stimulation + Rest
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger